Skip to main content
AI-powered literature reviews

EVID AI evidence synthesis: Your fast track to evidence intelligence

EVID AI is a full-spectrum evidence synthesis platform built for rapid evidence queries, targeted reviews, literature surveillance, and end-to-end SLRs. Developed in-house by our scientists to support client work and refined through two years of real-world use, it is also available for direct access to support day-to-day research.

global data partners
Run it yourself. Run it with Genesis. Or have Genesis run it for you.

Want to experience the power of EVID AI for yourself?

Submit your details to obtain FREE use through 2026!
Request access

Meeting your literature review needs

Tight timelines:
  • Market landscaping
  • Competitive intelligence
  • New indication overview
  • Literature surveillance
  • KOL identification and profiling
  • Target journal selection.
Focused research questions:
  • Early desk research
  • Quick identification of pertinent publications
  • Contextualization of results from select studies
  • Evaluation of scientific communication targets.
Enhanced literature reviews:
  • Manage all types of literature reviews
  • Conduct non-systematic literature literature reviews with additional AI-assisted quality control
  • Conduct systematic literature review search and screening in a single platform.
EVID AI platform

Leverage our AI-powered evidence synthesis solutions

Free up your professional resources to focus on strategic priorities by allowing our dedicated evidence synthesis teams to employ this unique AI-powered literature review platform on your behalf, providing transparent and reproducible evidence faster, more efficiently, and from a greater breadth of sources than through a traditional approach to providing biopharma evidence synthesis services.

EVID AI allows us to offer:

  • Literature reviews of higher quality and comprehensiveness, plus faster delivery
  • Ongoing reviews for competitor intelligence to keep ahead of the evidence base
  • Rapid answers to ad-hoc questions
  • Efficient landscape reviews
  • Quick-turnaround regulatory and HTA response generation
  • Optional AI-enhanced workflows for searching, screening, and summarizing evidence, guided and validated by human expertise.
EVID AI logo
Request access

“EVID’s ability to allow us to filter on study types and outcomes saved us weeks of manual effort, especially important for this urgent update.”

- Pharma Client

Looking for a partner to provide fast, accurate healthcare literature reviews and comprehensive evidence synthesis?

Explore our evidence synthesis services

EVID AI use cases

Simplify how you navigate the complex landscape of scientific literature. Discover our latest developments.

Download the EVID AI brochure

EVID AI minimizes set-up burden, alleviates the need to allocate and manage screening, and allows us to centralize the initial screen phase of literature review work in a single platform.

Senior Director, Evidence Synthesis

Publishing RWE studies can be tricky. We use EVID to identify journals with a track record of publishing RWE studies…[and] to identify disease-area experts at academic centers who have authored RWE studies in the past.

Senior Director, Scientific and Value Communications

EVID AI search accelerates KOL recruitment through quicker identification and increased data accuracy. I used the expert search function to recruit German Infectious Diseases experts, a Haematologist from Malaysia, and HTA and HE experts from Vietnam and Poland.

Associate Director, Global Stakeholder Management

EVID's ability to filter on study types and outcomes saved us weeks of manual effort, especially important for the urgency of the update we were undertaking.

Pharma client

Run it yourself. Run it with Genesis. Or have Genesis run it for you.

Request free access to EVID AI

Headquarters:

HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US